rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
143	Hyperlipidemia, combined, 1	C0020473	17	293	7.39164285335e-11	4.04068946029952e-05	FABP2,APOA4,APOE,CDCP1,SLC25A13,APOC3,F7,ALB,APOC1,APOC2,APOA1,APOA2,LIPE,PTGS1,CYP2C9,NPHS1,HP
144	Epidermolysis bullosa simplex, Cockayne-Touraine type	C0079298	7	28	7.75129960218e-11	4.0689460299519633e-05	GFAP,KRT9,KRT1,FN1,KRT14,KRT10,KRT5
145	Palmar hyperkeratosis	C0240641	7	28	7.75129960218e-11	4.097202599604408e-05	KRT6A,KRT9,KRT1,KRT16,KRT14,KRT10,KRT5
146	Autosomal dominant non-syndromic sensorineural deafness type DFNA	C0443147	32	1262	7.8291262362e-11	4.1254591692568526e-05	GFAP,CAMTA1,SERPING1,APOE,KRT6B,LDB3,TTN,PLAG1,GJC2,KRT9,KRT13,KRT1,CFH,APOA1,NLRC4,ITGA2,CST3,TTR,GSN,SCN5A,KCNMA1,AP4E1,SPAST,FN1,KRT16,KRT14,CYP2C9,SETX,RYR2,KRT10,DICER1,KRT5
147	Plantar hyperkeratosis	C1856954	7	32	9.14388564865e-11	4.153715738909297e-05	KRT6A,KRT9,KRT1,KRT16,KRT14,KRT10,KRT5
148	Diabetes mellitus type 2	C0011860	41	1972	9.77914416112e-11	4.1819723085617404e-05	FABP2,CAMTA1,APOA4,APOE,FABP6,DGKG,DCD,CRB1,APOC3,F7,CTSL,HPX,GRAP2,CFH,PEG3,ALB,APOC1,APOC2,ST13,APOA1,ITGA2,CST3,CFB,TTR,GSN,AHSG,FABP4,ATM,SCN5A,APOA2,DMD,FN1,KRT16,LIPE,TOMM40,CYP2C9,THRAP3,TSC22D1,NPHS1,DICER1,HP
149	Palmoplantar keratoderma, nonepidermolytic, focal	C0022596	12	156	1.15144560553e-10	4.210228878214185e-05	KRT6A,KRT6B,LDB3,TTN,KRT9,KRT1,SCN5A,DMD,KRT16,KRT14,KRT10,KRT5
152	Hyperkeratosis	C0870082	14	258	3.35494521053e-10	4.2949985871715175e-05	KRT6A,KRT6B,LDB3,TTN,KRT9,KRT13,KRT1,APOC1,SCN5A,DMD,KRT16,KRT14,KRT10,KRT5
153	Epidermal thickening	C0494876	15	309	4.27231472422e-10	4.323255156823962e-05	KRT6A,KRT6B,LDB3,TTN,KRT9,KRT13,KRT1,SCN5A,DMD,KRT16,CHKB,KRT14,LIPE,KRT10,KRT5
154	Hypertriglyceridemia result	C1522137	7	44	6.22900619973e-10	4.351511726476406e-05	FABP2,APOA4,APOE,APOC3,APOC2,APOA1,APOA2
155	Hyperlipidemia, familial combined	C0020474	9	95	9.91828175145e-10	4.3797682961288496e-05	FABP2,APOA4,APOE,APOC3,ALB,APOA1,APOA2,FN1,LIPE
157	Thickened skin	C0241165	15	339	1.5362928707e-09	4.436281435433739e-05	KRT6A,KRT6B,LDB3,TTN,KRT9,KRT13,KRT1,SCN5A,DMD,KRT16,CHKB,KRT14,LIPE,KRT10,KRT5
158	Coronary heart disease 7	C0010054	22	754	1.79707948522e-09	4.464538005086183e-05	FABP2,APOA4,APOE,TTN,APOC3,F7,CFH,ALB,APOC1,APOA1,ITGA2,CST3,AHSG,FABP4,ATM,SCN5A,APOA2,PF4V1,FN1,PTGS1,CYP2C9,HP
160	Myofibrillar myopathy, BAG3-related	C2678065	6	34	2.69731725844e-09	4.521051144391071e-05	LDB3,TTN,CFH,GSN,DMD,FN1
161	Carotid Atherosclerosis	C0577631	9	111	4.44769276964e-09	4.549307714043515e-05	FABP2,APOA4,APOE,APOC3,F7,APOA1,ITGA2,FABP4,HP
162	Abnormality of the plantar skin of foot	C4020946	7	57	4.70832883792e-09	4.577564283695959e-05	KRT6A,KRT9,KRT1,KRT16,KRT14,KRT10,KRT5
163	Myocardial Infarction	C0027051	25	1019	5.82069603627e-09	4.605820853348404e-05	FABP2,GFAP,APOA4,SERPING1,APOE,CDCP1,APOC3,F7,CFH,APOC1,APOA1,ITGA2,CST3,GSN,AHSG,FABP4,ATM,SCN5A,APOA2,KCNMA1,FN1,KRT16,PTGS1,CYP2C9,HP
166	Kidney Failure, Chronic	C0022661	19	616	7.73867625536e-09	4.690590562305736e-05	FABP2,APOE,APOC3,F7,ADRA1B,CFH,KLK3,ALB,APOA1,ITGA2,CST3,TTR,GSN,AHSG,ATM,PTGS1,CYP2C9,NPHS1,HP
168	Hypertriglyceridemia	C0020557	9	119	8.66169502789e-09	4.7471037016106245e-05	FABP2,APOA4,APOE,SLC25A13,APOC3,APOC2,APOA1,APOA2,LIPE
169	Abnormality of metabolism/homeostasis	C4021768	32	1607	8.99336349836e-09	4.775360271263069e-05	CAMTA1,SERPING1,PALB2,APOE,LDB3,TTN,CRB1,SLC25A13,APOC3,GJC2,KRT9,KRT1,CFH,ALB,APOC2,APOA1,NLRC4,CST3,TTR,GSN,ATM,SCN5A,DMD,TRAPPC11,FN1,CHKB,KRT14,LIPE,CYP2C9,SETX,NPHS1,DICER1
171	Coronary Artery Disease	C1956346	29	1366	1.06819231238e-08	4.831873410567957e-05	FABP2,CAMTA1,APOA4,PALB2,APOE,APOC3,F7,PPBP,CFH,ALB,APOC1,APOC2,APOA1,ITGA2,CST3,CFB,AHSG,FABP4,ATM,SCN5A,APOA2,CFD,PF4V1,FN1,LIPE,PTGS1,CYP2C9,KRT5,HP
172	Abnormality of the skin	C0037268	29	1376	1.25551882224e-08	4.8601299802204015e-05	SERPING1,KRT6A,PALB2,APOE,KRT6B,LDB3,TTN,CRB1,GJC2,KRT9,KRT13,KRT1,APOC1,APOC2,APOA1,NLRC4,ITGA2,GSN,ATM,SCN5A,DMD,KRT16,CHKB,KRT14,LIPE,SETX,KRT10,DICER1,KRT5
173	Diabetes Mellitus, Type 1	C0011849	37	2081	1.32305881806e-08	4.888386549872845e-05	FABP2,GFAP,APOA4,PALB2,APOE,TTN,CRB1,APOC3,F7,ADRA1B,CTSL,GRAP2,CFH,EXOC6,ALB,ST13,APOA1,CST3,CFB,GSN,AHSG,FABP4,ATM,APOA2,DMD,KCNMA1,CFD,FN1,KRT16,LIPE,PTGS1,TOMM40,GABBR1,CYP2C9,RYR2,DICER1,HP
174	Hyperlipoproteinemia	C0020476	6	43	1.49958065965e-08	4.9166431195252894e-05	APOE,APOC3,ALB,APOC2,APOA1,APOA2
175	body mass	C0518010	8	94	1.55543448122e-08	4.9448996891777344e-05	FABP2,APOA4,APOE,APOC3,F7,APOA1,APOA2,LIPE
181	Cardiovascular Diseases	C0007222	24	1029	3.04324048184e-08	5.114439107092399e-05	FABP2,APOA4,APOE,APOC3,F7,PPBP,CFH,ALB,APOC1,APOC2,APOA1,ITGA2,CST3,AHSG,FABP4,ATM,SCN5A,FN1,PTGS1,TOMM40,CYP2C9,RYR2,KRT5,HP
182	Insulin resistance syndrome	C3714619	6	48	3.32714851226e-08	5.1426956767448436e-05	FABP2,APOA4,ALB,APOC1,APOC2,APOA2
183	 Cerebrovascular disease, occlusive (3)	C0007820	7	73	3.42812129794e-08	5.170952246397288e-05	FABP2,APOA4,APOE,APOC3,F7,APOA1,ITGA2
184	Hyperhidrosis	C0020458	8	104	3.78277790203e-08	5.1992088160497314e-05	KRT6A,KRT6B,KRT9,KRT1,NLRC4,KRT16,KRT14,KRT5
185	Abnormal blistering of the skin	C2132198	7	74	3.81903380031e-08	5.227465385702176e-05	KRT6A,KRT6B,KRT1,KRT16,KRT14,KRT10,KRT5
186	Acute Coronary Syndrome	C0948089	13	320	4.13860592463e-08	5.25572195535462e-05	APOE,APOC3,F7,PPBP,ALB,APOA1,ITGA2,CST3,GSN,FABP4,ATM,PTGS1,CYP2C9
187	Kidney Diseases	C0022658	20	755	4.54370180369e-08	5.283978525007064e-05	FABP2,APOA4,APOE,APOC3,F7,ADRA1B,CTSL,CFH,ALB,APOA1,CST3,TTR,GSN,AHSG,ATM,FN1,CYP2C9,RYR2,NPHS1,HP
188	Abnormality of circulating protein level	C4023679	12	274	4.99761105832e-08	5.3122350946595085e-05	LDB3,TTN,ALB,ATM,SCN5A,DMD,TRAPPC11,FN1,CHKB,LIPE,SETX,NPHS1
189	Arteriosclerosis	C0003850	24	1059	5.29213687317e-08	5.340491664311953e-05	FABP2,APOA4,APOE,APOC3,F7,CTSL,GRAP2,CFH,ALB,APOC2,APOA1,ITGA2,CST3,TTR,AHSG,FABP4,ATM,APOA2,DMD,FN1,LIPE,PTGS1,CYP2C9,HP
190	Dyslipidemias	C0242339	11	228	5.37175058879e-08	5.368748233964397e-05	FABP2,APOE,APOC3,F7,APOC2,APOA1,AHSG,FABP4,KRT16,LIPE,HP
193	Abnormality of cardiovascular system electrophysiology	C0243050	30	1568	6.43970082814e-08	5.453517942921729e-05	SERPING1,PALB2,APOE,LDB3,TTN,CRB1,F7,KRT9,KRT1,TIAM1,ALB,APOC2,APOA1,NLRC4,ITGA2,CST3,TTR,GSN,ATM,SCN5A,DMD,FN1,KRT16,CHKB,KRT14,OBSL1,SETX,RYR2,KRT10,KRT5
194	Dermal atrophy	C0151514	11	237	8.20084415931e-08	5.481774512574174e-05	APOE,TTN,CRB1,CFH,KLK3,APOC1,KRT14,PTGS1,CYP2C9,SETX,KRT5
195	Ichthyosis, congenital, autosomal recessive 12	C0020757	9	152	8.9776610479e-08	5.510031082226618e-05	KRT6A,KRT6B,KRT9,KRT1,DMD,KRT16,CHKB,KRT14,KRT10
196	Abnormality of blood and blood-forming tissues	C0241657	27	1335	9.20331221232e-08	5.538287651879062e-05	SERPING1,PALB2,APOE,LDB3,TTN,CRB1,F7,KRT9,KRT1,APOC2,APOA1,NLRC4,ITGA2,CST3,TTR,ATM,SCN5A,DMD,FN1,KRT16,KRT14,OBSL1,CYP2C9,SETX,RYR2,KRT10,KRT5
197	Familial type 3 hyperlipoproteinemia	C0020479	5	34	1.00371142175e-07	5.566544221531506e-05	APOE,APOC3,APOC1,APOC2,APOA1
199	Abnormality of skin morphology	C4023528	26	1261	1.06553152301e-07	5.623057360836394e-05	SERPING1,KRT6A,PALB2,APOE,KRT6B,LDB3,TTN,CRB1,KRT9,KRT13,KRT1,APOC2,APOA1,NLRC4,ITGA2,GSN,ATM,SCN5A,DMD,KRT16,CHKB,KRT14,LIPE,SETX,KRT10,KRT5
200	Atherosclerosis	C0004153	26	1271	1.24833566817e-07	5.651313930488839e-05	FABP2,APOA4,APOE,APOC3,F7,CTSL,GRAP2,CFH,ALB,APOC1,APOC2,APOA1,ITGA2,CST3,TTR,AHSG,FABP4,ATM,APOA2,DMD,FN1,LIPE,PTGS1,CYP2C9,ITGB5,HP
201	Cholecystolithiasis	C0947622	7	86	1.25248715177e-07	5.679570500141283e-05	APOA4,APOE,FABP6,APOC3,APOC1,APOA1,TTR
202	Vascular Diseases	C0042373	14	410	1.3850366809e-07	5.707827069793727e-05	APOE,APOC3,F7,ALB,APOA1,ITGA2,CST3,TTR,AHSG,ATM,DMD,PF4V1,CYP2C9,HP
205	Neoplasm of the liver	C0023903	26	1290	1.67811974539e-07	5.79259677875106e-05	APOA4,SERPING1,APOE,DCD,SLC25A13,APOC3,F7,HPX,GRAP2,TIAM1,ITIH1,BBC3,ALB,APOC2,ST13,APOA1,TTR,AHSG,ATM,FN1,LIPE,CYP2C9,DERL1,SLC1A5,KRT5,HP
206	Lipoatrophy	C0023787	9	163	1.72937557941e-07	5.820853348403504e-05	APOE,LDB3,TTN,APOC3,ALB,FABP4,SCN5A,DMD,LIPE
207	Proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis	C0033687	10	209	1.95713547479e-07	5.849109918055948e-05	FABP2,APOE,CTSL,CFH,ALB,APOA1,FN1,CYP2C9,NPHS1,HP
208	Acute myocardial ischemia	C0151744	15	484	2.06336616349e-07	5.8773664877083925e-05	APOA4,APOE,TTN,APOC3,F7,CFH,ALB,APOA1,ITGA2,ATM,SCN5A,DMD,PDE4B,CYP2C9,RYR2
209	Hypercholesterolemia, autosomal dominant, type B	C0020443	10	212	2.25833332812e-07	5.905623057360836e-05	FABP2,APOA4,APOE,SLC25A13,APOC3,ALB,APOA1,FABP4,APOA2,CYP2C9
218	Abnormality of the immune system	C4021753	24	1164	3.15496937797e-07	6.159932184232835e-05	SERPING1,PALB2,APOE,LDB3,TTN,SLC25A13,GJC2,KRT9,KRT1,CFH,APOC2,APOA1,NLRC4,CFB,ATM,SCN5A,DMD,CFD,KRT16,KRT14,SETX,KRT10,NPHS1,KRT5
220	Restenosis	C0333186	10	220	3.2713165099e-07	6.216445323537723e-05	FABP2,APOA4,SERPING1,APOE,APOC3,F7,ALB,ITGA2,ATM,HP
221	Alzheimer Disease	C0002395	30	1699	3.76998329443e-07	6.244701893190167e-05	GFAP,SERPING1,APOE,SH3BP5,APOC3,F7,CTSL,GRAP2,CFH,KLK3,ALB,APOC1,APOC2,APOA1,ITGA2,CST3,CFB,TTR,GSN,AHSG,ATM,KCNMA1,SPAST,FN1,KRT14,PTGS1,TOMM40,GABBR1,PCED1B,HP
223	Obesity	C0028754	35	2181	4.20549807645e-07	6.301215032495055e-05	FABP2,APOA4,APOE,FABP6,DGKG,CRB1,APOC3,F7,ADRA1B,CTSL,GRAP2,TIAM1,CFH,PEG3,CROT,ALB,APOC1,ST13,APOA1,CST3,CFB,AHSG,FABP4,ATM,APOA2,KCNMA1,CFD,FN1,KRT16,LIPE,CYP2C9,THRAP3,NCOA3,DICER1,HP
224	Myopathy, scapulohumeroperoneal	C0026848	14	450	4.53563626102e-07	6.329471602147499e-05	GFAP,APOE,LDB3,TTN,CFH,ALB,TTR,SCN5A,DMD,TRAPPC11,CHKB,OBSL1,CYP2C9,RYR2
225	Familial hypercholesterolemia	C0020445	9	182	4.80601060726e-07	6.357728171799944e-05	FABP2,APOA4,APOE,APOC3,CFH,ALB,APOC2,APOA1,APOA2
227	Mild cognitive impairment	C1270972	8	141	5.19511247132e-07	6.414241311104832e-05	GFAP,APOE,APOC2,CST3,TTR,DMD,KRT14,TOMM40
228	Stage 5 chronic kidney disease	C2316810	10	234	6.03667228094e-07	6.442497880757277e-05	APOE,CFH,KLK3,ALB,APOA1,TTR,GSN,AHSG,FN1,NPHS1
229	Abnormality of immune system physiology	C4023616	20	884	6.14783409292e-07	6.47075445040972e-05	SERPING1,PALB2,APOE,SLC25A13,GJC2,KRT9,KRT1,CFH,APOC2,APOA1,NLRC4,CFB,ATM,CFD,KRT16,KRT14,SETX,KRT10,NPHS1,KRT5
230	Drug Eruptions	C0011609	4	25	6.33054645593e-07	6.499011020062164e-05	APOC3,APOC2,APOA1,TTR
231	Chronic kidney disease	C1561643	12	342	6.35029890339e-07	6.527267589714608e-05	APOA4,APOE,CFH,ALB,ITGA2,CST3,AHSG,ATM,FN1,PTGS1,TOMM40,HP
235	Skin Diseases, Genetic	C0037277	5	46	6.53291183927e-07	6.640293868324386e-05	KRT9,KRT1,KRT14,KRT10,KRT5
236	Bleeding with minor or no trauma	C0019080	6	74	7.00183103386e-07	6.66855043797683e-05	APOE,F7,KRT1,ITGA2,PTGS1,CYP2C9
237	Oral leukoplakia	C0023532	6	75	7.67873691965e-07	6.696807007629274e-05	KRT6A,KRT6B,ATM,KRT16,KRT14,KRT5
238	Abnormality of the integument	C4025761	29	1665	7.79565431208e-07	6.725063577281717e-05	SERPING1,KRT6A,PALB2,APOE,KRT6B,LDB3,TTN,CRB1,GJC2,KRT9,KRT13,KRT1,APOC2,APOA1,NLRC4,ITGA2,GSN,ATM,SCN5A,DMD,KRT16,CHKB,KRT14,LIPE,OBSL1,SETX,KRT10,DICER1,KRT5
239	Hypohidrosis	C0020620	8	150	8.74636346793e-07	6.753320146934162e-05	KRT6A,KRT6B,KRT9,KRT1,NLRC4,KRT16,KRT14,KRT5
240	Alzheimer Disease, Late Onset	C0494463	6	77	9.19859291182e-07	6.781576716586607e-05	GFAP,APOE,APOC1,APOC2,CST3,TOMM40
241	Brain Ischemia	C0007786	13	415	9.66119263812e-07	6.809833286239051e-05	FABP2,GFAP,APOE,F7,CTSL,BBC3,ALB,ITGA2,TTR,ATM,SCN5A,PTGS1,KRT5
242	Cerebral Amyloid Angiopathy	C0085220	5	50	1.08376369901e-06	6.838089855891496e-05	APOE,APOA1,CST3,TTR,GSN
243	Vascular skin abnormality	C0162819	12	359	1.09254637193e-06	6.866346425543939e-05	SERPING1,APOE,KRT9,KRT1,NLRC4,ITGA2,ATM,KRT16,KRT14,SETX,KRT10,KRT5
244	Azorean disease	C0024408	6	80	1.19459101278e-06	6.894602995196383e-05	GFAP,APOE,BBC3,CST3,TTR,ATM
254	Age-related macular degeneration 2	C0242383	13	423	1.20974696716e-06	7.177168691720826e-05	SERPING1,APOE,APOC3,CFH,ALB,APOC1,CST3,CFB,ATM,CFD,TOMM40,DICER1,HP
255	Old myocardial infarction	C0155668	4	29	1.38426800511e-06	7.205425261373269e-05	APOA4,APOE,APOA1,CYP2C9
256	Preeclampsia/eclampsia 1	C0032914	12	371	1.57337086848e-06	7.233681831025714e-05	FABP2,APOE,APOC3,F7,CFH,APOA1,FABP4,FN1,PTGS1,NPHS1,SLC1A5,HP
257	Membranous nephropathy, susceptibility to	C0017665	6	84	1.66505049382e-06	7.261938400678158e-05	APOE,CFH,ALB,APOA1,FN1,NPHS1
258	Metabolic Syndrome X	C0524620	16	638	1.6880833702e-06	7.290194970330601e-05	FABP2,APOA4,APOE,APOC3,ALB,APOC1,APOC2,APOA1,AHSG,FABP4,APOA2,KRT16,LIPE,PTGS1,TOMM40,NCOA3
259	Onset	C0206132	17	713	1.76693149845e-06	7.318451539983046e-05	GFAP,APOE,LDB3,TTN,GJC2,CFH,SACS,ITGA2,TTR,GSN,SCN5A,DMD,AP4E1,CHKB,KRT14,NPHS1,KRT5
261	Erythema	C0041834	7	123	1.96622000237e-06	7.374964679287935e-05	SERPING1,KRT9,KRT1,NLRC4,KRT16,KRT10,KRT5
262	Inflammation	C0021368	16	647	2.03858638637e-06	7.403221248940378e-05	APOA4,SERPING1,APOE,PRSS3,APOC3,F7,CFH,APOC1,APOA1,CST3,AHSG,APOA2,FN1,LIPE,PTGS1,HP
263	Diabetic Angiopathies	C0011875	6	88	2.28144228109e-06	7.431477818592823e-05	APOA4,APOE,F7,ALB,FN1,HP
264	Dysmorphic features	C0432072	5	57	2.37994525809e-06	7.459734388245268e-05	CAMTA1,JARID2,PTGS1,DERL1,DICER1
265	Nail dystrophy	C0221260	6	89	2.46219068722e-06	7.487990957897712e-05	KRT6A,KRT6B,KRT1,KRT16,KRT14,KRT5
267	Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	C0152025	6	90	2.65476875694e-06	7.544504097202599e-05	LDB3,ALB,APOA1,TTR,GSN,SETX
268	Abnormality of the level of lipoprotein cholesterol	C4023615	4	33	2.70660097612e-06	7.572760666855044e-05	APOE,SLC25A13,APOC3,APOA1
269	Abnormality of lipid metabolism	C4025650	8	172	2.72610426599e-06	7.601017236507488e-05	APOE,SLC25A13,APOC3,ALB,APOC2,APOA1,LIPE,NPHS1
270	Amyloidosis	C0002726	7	129	2.81183685902e-06	7.629273806159933e-05	APOE,APOA1,CST3,TTR,GSN,APOA2,HP
271	Insulin Resistance	C0021655	11	332	2.92080551123e-06	7.657530375812377e-05	FABP2,APOE,APOC3,F7,APOA1,FABP4,ATM,APOA2,LIPE,RYR2,TSC22D1
275	Geographic Atrophy	C1536085	4	34	3.15592594613e-06	7.770556654422153e-05	CFH,CFB,CFD,DICER1
276	Plaque, Atherosclerotic	C0011389	9	226	3.4125190489e-06	7.798813224074597e-05	GFAP,APOA4,SERPING1,APOE,ALB,APOA1,CST3,TTR,GSN
277	Congenital onset	C1836142	8	185	4.94791821615e-06	7.827069793727042e-05	TTN,ITGA2,SCN5A,AP4E1,CHKB,KRT14,NPHS1,KRT5
278	SUDDEN INFANT DEATH SYNDROME	C0038644	6	99	5.02685129922e-06	7.855326363379487e-05	APOE,CTSL,ATM,SCN5A,CYP2C9,RYR2
279	Mesangiocapillary glomerulonephritis, type II	C0017662	4	38	5.56982501032e-06	7.88358293303193e-05	CFH,ALB,FN1,KRT5
280	Dermatosis NOS	C0037274	13	483	5.61152132206e-06	7.911839502684374e-05	GFAP,KRT6A,DCD,F7,KRT9,GRAP2,KRT1,CFH,PDE4B,KRT14,PTGS1,KRT10,KRT5
290	Fetal Membranes, Premature Rupture	C0015943	8	194	7.27193707506e-06	8.194405199208817e-05	FABP2,APOE,APOC3,F7,APOA1,FN1,PTGS1,HP
291	Abnormality of circulating enzyme level	C4023591	8	194	7.27193707506e-06	8.22266176886126e-05	LDB3,TTN,SCN5A,DMD,TRAPPC11,CHKB,LIPE,SETX
292	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	C0740394	5	69	7.35259622042e-06	8.250918338513705e-05	FABP2,APOA4,APOE,APOC3,APOA1
293	Glucose intolerance	C0271650	10	304	7.56253321232e-06	8.279174908166149e-05	FABP2,APOE,CTSL,ALB,APOC2,APOA1,ATM,FN1,RYR2,HP
294	Elevated serum creatine phosphokinase	C0241005	8	195	7.5800348196e-06	8.307431477818594e-05	LDB3,TTN,SCN5A,DMD,TRAPPC11,CHKB,LIPE,SETX
295	Influenza	C0021400	13	497	7.75725155056e-06	8.335688047471037e-05	SERPING1,GRAP2,PPBP,CFH,ALB,ST13,NLRC4,TTR,PTGS1,SETX,SLA2,KRT5,HP
296	Papilloma	C0030354	8	196	7.89926211386e-06	8.363944617123481e-05	APOE,KRT9,KRT1,PEG3,TTR,KRT16,KRT14,KRT5
297	Spots on skin	C0848332	8	198	8.57240653462e-06	8.392201186775926e-05	APOE,KLK3,APOA1,ATM,DMD,FN1,KRT10,HP
298	Ischemia	C0022116	15	647	8.83460589962e-06	8.42045775642837e-05	GFAP,APOE,TTN,APOC3,F7,GRAP2,ALB,TTR,ATM,SCN5A,DMD,KCNMA1,FN1,CYP2C9,SLC1A5
301	Obesity, Visceral	C2936179	4	42	9.2355093434e-06	8.505227465385703e-05	FABP2,APOC3,F7,APOA2
302	Abnormal inflammatory response	C4022805	14	581	1.02922650951e-05	8.533484035038146e-05	APOE,SLC25A13,GJC2,KRT9,KRT1,APOC2,APOA1,NLRC4,CFB,ATM,KRT16,KRT14,KRT10,KRT5
303	Increased inflammatory response	C4022803	14	581	1.02922650951e-05	8.56174060469059e-05	APOE,SLC25A13,GJC2,KRT9,KRT1,APOC2,APOA1,NLRC4,CFB,ATM,KRT16,KRT14,KRT10,KRT5
310	Abnormality of the nervous system	C0497552	35	2512	1.09206292649e-05	8.759536592257699e-05	GFAP,CAMTA1,SERPING1,KRT6A,PALB2,APOE,KRT6B,LDB3,TTN,CRB1,SLC25A13,F7,GJC2,SACS,APOA1,NLRC4,CST3,TTR,GSN,ATM,SCN5A,DMD,KCNMA1,TRAPPC11,AP4E1,SPAST,FN1,KRT16,CHKB,KRT14,OBSL1,SETX,RYR2,DICER1,KRT5
311	Muscle weakness	C0030552	16	735	1.09418160966e-05	8.787793161910144e-05	LDB3,TTN,GJC2,TIAM1,CFH,SACS,TTR,GSN,DMD,TRAPPC11,SPAST,CHKB,KRT14,LIPE,SETX,KRT5
312	Proximal muscle weakness	C0221629	6	112	1.13656587674e-05	8.816049731562588e-05	LDB3,TTN,DMD,TRAPPC11,CHKB,LIPE
313	Nephrotic Syndrome, Minimal Change	C1704321	4	44	1.16625341133e-05	8.844306301215033e-05	APOE,HPX,ALB,NPHS1
314	Limb-girdle muscular dystrophy, type 2L	C0686353	5	75	1.19439250433e-05	8.872562870867478e-05	LDB3,TTN,DMD,TRAPPC11,OBSL1
315	Abnormality of humoral immunity	C3150510	7	157	1.200616011e-05	8.900819440519921e-05	KRT9,KRT1,CFH,CFB,ATM,CFD,SETX
316	Nephrotic syndrome, type 5, with or without ocular abnormalities	C0027726	9	263	1.29161636069e-05	8.929076010172366e-05	APOA4,APOE,CTSL,HPX,ALB,APOA1,GSN,FN1,NPHS1
317	Heart Diseases	C0018799	11	386	1.33919723564e-05	8.957332579824808e-05	APOE,TTN,APOC3,ALB,TTR,SCN5A,DMD,PF4V1,LIPE,CYP2C9,RYR2
320	Neuropathy ataxia retinitis pigmentosa syndrome	C0442874	9	265	1.37908854596e-05	9.042102288782142e-05	SERPING1,APOE,LDB3,SACS,ALB,TTR,GSN,APOA2,SETX
321	Cardiomyopathy, Dilated	C0007193	12	454	1.39233915497e-05	9.070358858434587e-05	GFAP,APOE,LDB3,TTN,CTSL,KRT9,ATM,SCN5A,DMD,FN1,CHKB,RYR2
322	Thromboembolism	C0040038	6	118	1.59887979558e-05	9.09861542808703e-05	APOA4,F7,CFH,ITGA2,ATM,CYP2C9
323	Hematuria	C0018965	5	79	1.61242252786e-05	9.126871997739475e-05	F7,CFH,APOA1,FN1,NPHS1
328	Acute kidney injury	C0022660	9	270	1.62040449081e-05	9.268154846001696e-05	APOE,CFH,ALB,CST3,CFB,ATM,FN1,CYP2C9,HP
329	Drusen	C1260959	4	47	1.62053664795e-05	9.29641141565414e-05	APOE,CFH,ALB,CFB
330	Choroidal Neovascularization	C0600518	4	47	1.62053664795e-05	9.324667985306585e-05	SERPING1,F7,CFH,CFB
337	Anemia, Sickle Cell	C0002895	9	271	1.67279392501e-05	9.522463972873694e-05	APOE,F7,HPX,PPBP,APOA1,ITGA2,FN1,CYP2C9,HP
338	Hypertension	C0020538	26	1647	1.67552081308e-05	9.550720542526137e-05	FABP2,PALB2,APOE,APOC3,F7,ADRA1B,GRAP2,TIAM1,PPBP,CFH,ALB,APOC1,APOA1,ITGA2,CST3,TTR,ATM,DMD,KCNMA1,FN1,PTGS1,GABBR1,CYP2C9,RYR2,NPHS1,HP
339	Cerebral edema	C0006114	5	80	1.73347465638e-05	9.578977112178581e-05	GFAP,APOE,SLC25A13,MYL4,DMD
340	Obstructive sleep apnea	C0520679	7	166	1.79925625847e-05	9.607233681831026e-05	APOE,ADRA1B,GSN,FABP4,PTGS1,GABBR1,HP
341	Focal segmental glomerulosclerosis	C0017668	6	121	1.88262391364e-05	9.63549025148347e-05	APOE,CFH,ALB,ATM,FN1,NPHS1
342	Carcinoma of colon	C0699790	28	1856	1.92163339219e-05	9.663746821135915e-05	APOE,CDCP1,F7,GRAP2,TIAM1,PPBP,CFH,JARID2,BBC3,ALB,APOC2,SCAF1,ST13,APOA1,GSN,AHSG,ATM,CTAGE5,SCN5A,CABLES1,FN1,PTGS1,RANBP2,CYP2C9,NPHS1,NCOA3,DICER1,RANBP3
344	Ischemic stroke	C0948008	11	401	1.95205085616e-05	9.720259960440803e-05	APOE,APOC3,F7,CFH,APOA1,ITGA2,AHSG,FABP4,ATM,PTGS1,CYP2C9
345	Von Willebrand disease, recessive form	C0042974	4	49	1.9926734437e-05	9.748516530093248e-05	GFAP,F7,ITIH1,ITGA2
346	Diabetic Nephropathies	C0011881	14	616	2.03910848697e-05	9.77677309974569e-05	FABP2,APOE,APOC3,CFH,ALB,APOC1,CST3,AHSG,FN1,KRT16,PTGS1,TSC22D1,NPHS1,HP
347	Duchenne muscular dystrophy	C0013264	6	123	2.09394451108e-05	9.805029669398135e-05	TTN,HPX,CFH,DMD,FN1,HP
348	Iron deficiency anemia	C0162316	4	50	2.20204024829e-05	9.833286239050579e-05	APOE,F7,CST3,FN1
349	Cholelithiasis	C0008350	7	171	2.22849904715e-05	9.861542808703024e-05	APOA4,APOE,FABP6,APOC3,APOC1,APOA1,TTR
350	Abnormality of the skin of the palm	C4073159	7	171	2.22849904715e-05	9.889799378355469e-05	KRT6A,KRT9,KRT1,KRT16,KRT14,KRT10,KRT5
351	Thrombophilia	C0398623	6	125	2.32445597655e-05	9.918055948007912e-05	APOA4,APOE,F7,KLK3,ALB,CYP2C9
352	Polycystic Ovary Syndrome	C0032460	12	477	2.3348189546e-05	9.946312517660357e-05	APOE,ADRA1B,KLK3,ALB,APOA1,FABP4,ATM,DMD,LIPE,CYP2C9,NCOA3,HP
353	Abnormality of the lower limb	C1096086	18	947	2.38154794576e-05	9.9745690873128e-05	KRT6A,PALB2,LDB3,TTN,GJC2,KRT9,KRT1,SACS,DMD,AP4E1,FN1,KRT16,KRT14,LIPE,OBSL1,SETX,KRT10,KRT5
354	Nephrosis	C0027720	4	51	2.4281189412e-05	0.00010002825656965244	CFH,ALB,APOA1,NPHS1
355	Aural atresia, congenital	C1842937	4	51	2.4281189412e-05	0.00010031082226617688	APOE,CST3,TTR,GSN
359	Adult onset ataxia with oculomotor apraxia	C1853562	6	127	2.57549574662e-05	0.00010144108505227466	APOE,LDB3,TTN,TTR,GSN,DMD
360	Abnormality of skin physiology	C4023527	9	286	2.65246997356e-05	0.00010172365074879909	GJC2,KRT9,KRT1,APOA1,NLRC4,KRT16,KRT14,KRT10,KRT5
361	Guillain-Barre syndrome, familial	C0018378	4	52	2.67181770294e-05	0.00010200621644532354	GFAP,SERPING1,APOE,ALB
362	Aneurysm, Ruptured	C0162869	3	26	2.67982948142e-05	0.00010228878214184799	APOE,ITGA2,FN1
363	Brain Hemorrhage, Traumatic	C0553692	3	26	2.67982948142e-05	0.00010257134783837242	F7,APOA1,ITGA2
364	Non-Hodgkin lymphoma	C0024305	13	556	2.69752568038e-05	0.00010285391353489687	APOA4,SERPING1,APOE,CFH,KLK3,CFB,ATM,APOA2,CFD,PTGS1,CYP2C9,NCOA3,HP
365	Atrial Fibrillation	C0004238	7	176	2.74053834985e-05	0.00010313647923142131	APOE,F7,MYL4,ITGA2,SCN5A,CYP2C9,RYR2
366	Inclusion Body Myopathy, Sporadic	C0751713	4	53	2.93409667058e-05	0.00010341904492794576	APOE,CST3,TTR,TOMM40
367	Abnormality of the fingernails	C4021782	6	130	2.99361158598e-05	0.00010370161062447018	KRT6A,KRT6B,KRT9,KRT1,KRT16,KRT14
368	Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads	C0237849	3	27	3.12933535873e-05	0.00010398417632099463	KRT1,APOC1,KRT10
369	Heart Failure	C0018801	16	803	3.3648462727e-05	0.00010426674201751908	APOE,TTN,GRAP2,JARID2,ALB,APOA1,CST3,TTR,GSN,ATM,SCN5A,DMD,PTGS1,CYP2C9,RYR2,HP
370	Pulmonary Embolism	C0034065	6	133	3.46602489911e-05	0.00010454930771404351	APOA4,APOE,ALB,FN1,CYP2C9,HP
377	Acute myocardial infarction	C0155626	8	237	3.56320923698e-05	0.0001065272675897146	APOE,F7,APOA1,ITGA2,CST3,SCN5A,DMD,HP
378	Hepatic steatosis	C0015695	11	427	3.60332860022e-05	0.00010680983328623906	FABP2,APOE,SLC25A13,APOC3,ALB,APOC1,APOA1,AHSG,LIPE,NCOA3,HP
379	Colon cancer	C0007102	26	1727	3.83629956259e-05	0.00010709239898276349	APOE,CDCP1,F7,GRAP2,PPBP,CFH,JARID2,BBC3,ALB,APOC2,SCAF1,ST13,APOA1,GSN,AHSG,ATM,SCN5A,CABLES1,FN1,PTGS1,RANBP2,CYP2C9,NPHS1,NCOA3,DICER1,RANBP3
380	Amyotrophic Lateral Sclerosis	C0002736	16	812	3.86606086404e-05	0.00010737496467928794	GFAP,APOA4,APOE,APOC3,F7,TIAM1,ITGA2,CST3,TTR,DMD,KCNMA1,SPAST,PDE4B,SETX,DERL1,PDZRN4
381	Motor Neuron Disease	C0085084	6	136	3.99807553417e-05	0.00010765753037581239	GFAP,APOE,DMD,SPAST,SETX,HP
382	Chronic Kidney Insufficiency	C0403447	7	186	4.06341499191e-05	0.00010794009607233681	APOA4,APOE,ALB,CST3,AHSG,ATM,HP
383	Oncocytoma, renal	C0346255	3	29	4.19061854234e-05	0.00010822266176886126	PLAG1,KLK3,DERL1
384	Proteinuria Adverse Event	C1962972	3	29	4.19061854234e-05	0.0001085052274653857	FABP2,CYP2C9,NPHS1
385	Becker muscular dystrophy	C0917713	3	29	4.19061854234e-05	0.00010878779316191015	TTN,DMD,FN1
386	Dementia familial British	C0011265	9	302	4.20378104694e-05	0.00010907035885843458	GFAP,APOE,ALB,APOC1,APOA1,CST3,TTR,SPAST,FN1
387	Retinopathy	C0035309	11	434	4.21583978737e-05	0.00010935292455495903	GFAP,APOE,CRB1,APOC3,CFH,ALB,APOA1,CFB,FN1,CYP2C9,HP
388	Phenotypic variability	C1837514	11	434	4.21583978737e-05	0.00010963549025148348	TTN,F7,GJC2,CFH,TTR,CFD,TRAPPC11,SPAST,KRT14,SETX,KRT5
478	Neoplasm of the skin	C0037286	11	438	4.60487042547e-05	0.00013506640293868324	KRT6B,KRT9,KRT1,TIAM1,KLK3,ATM,KRT16,KRT14,KRT10,DICER1,KRT5
479	Cerebral palsy, spastic quadriplegic, 3	C0007789	5	95	4.61186387479e-05	0.0001353489686352077	APOE,F7,CTSL,TTR,AP4E1
489	Verrucae	C0043037	3	30	4.80990752808e-05	0.0001381746256004521	KRT9,KRT1,KRT16
490	Peritoneal Fibrosis	C0521607	3	30	4.80990752808e-05	0.00013845719129697653	GRAP2,ATM,FN1
491	Abnormality of cholesterol metabolism	C4025656	4	59	4.95412086665e-05	0.000138739756993501	APOE,SLC25A13,APOC3,APOA1
492	Systemic arterial pressure	C1272641	11	442	5.02465370035e-05	0.00013902232269002543	APOA4,APOE,APOC3,F7,ADRA1B,APOA1,APOA2,KCNMA1,PDE4B,CYP2C9,RYR2
493	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	C0026850	9	311	5.37684493493e-05	0.00013930488838654988	TTN,CFH,PEG3,DMD,TRAPPC11,FN1,CHKB,LIPE,HP
494	Macular Degeneration	C0024437	7	194	5.47224517224e-05	0.00013958745408307433	SERPING1,APOE,CRB1,CFH,APOC1,CST3,CFB
495	Creutzfeldt-Jakob Disease, Sporadic	C1852467	3	31	5.49346872056e-05	0.00013987001977959875	GFAP,APOE,PTGS1
496	Atypical hemolytic-uremic syndrome 5	C2931788	3	31	5.49346872056e-05	0.0001401525854761232	CFH,CFB,HP
497	Chorioamnionitis	C0008495	7	195	5.67392035264e-05	0.00014043515117264765	FABP2,APOE,APOC3,F7,APOA1,FN1,PTGS1
498	Abnormality of adipose tissue	C4021524	6	144	5.75247326031e-05	0.0001407177168691721	LDB3,TTN,ALB,SCN5A,DMD,LIPE
499	Memory impairment	C0233794	8	255	6.27842929061e-05	0.00014100028256569652	GFAP,CAMTA1,APOE,APOC1,APOA1,SPAST,PTGS1,GABBR1
500	Cognition Disorders	C0009241	4	62	6.29969105362e-05	0.00014128284826222097	APOE,APOC1,CST3,SPAST
501	Meningococcal Infections	C0025303	4	62	6.29969105362e-05	0.00014156541395874542	SERPING1,CFH,CFB,CFD
502	Drug-Induced Liver Injury	C0860207	7	198	6.31645175202e-05	0.00014184797965526984	APOE,HPX,ALB,APOA1,TTR,GSN,CYP2C9
510	Blood pressure finding	C1271104	10	386	6.76279673196e-05	0.00014410850522746538	APOA4,APOE,APOC3,ADRA1B,APOA1,APOA2,KCNMA1,PDE4B,CYP2C9,RYR2
511	Cognitive Dysfunction	C0338656	15	769	7.08484729858e-05	0.00014439107092398983	KRT6A,APOE,KRT6B,GJC2,JARID2,ALB,APOC1,APOA1,CST3,TTR,ATM,DMD,SPAST,KRT16,TOMM40
512	Corneal dystrophy, Fuchs endothelial 1	C0010036	4	64	7.34229206558e-05	0.00014467363662051428	KRT6A,KRT6B,GSN,KRT16
513	Premature Obstetric Labor	C0022876	7	203	7.52142716978e-05	0.0001449562023170387	FABP2,APOE,APOC3,F7,APOA1,FN1,PTGS1
514	Disorders of lipoid metabolism	C0154251	4	65	7.9109772782e-05	0.00014523876801356315	FABP2,APOE,APOC3,APOA2
515	Hemolytic uremic syndrome	C0019061	4	65	7.9109772782e-05	0.0001455213337100876	CFH,ALB,ITGA2,CFB
516	Recurrent skin infections	C1853193	4	65	7.9109772782e-05	0.00014580389940661203	GJC2,KRT1,KRT14,KRT5
523	Congenital Myotonic Dystrophy	C0410226	6	153	8.43239769475e-05	0.00014778185928228315	APOE,LDB3,APOC1,APOC2,SCN5A,DMD
524	Unspecified visual loss	C3665346	4	66	8.51296845014e-05	0.00014806442497880757	CRB1,CFH,CFB,TTR
525	Glomerulonephritis, Membranous	C0017658	8	267	8.92285991776e-05	0.00014834699067533202	APOE,CFH,ALB,ITGA2,CFB,CFD,FN1,NPHS1
526	Impaired vibratory sensation	C1295585	3	35	8.95097052579e-05	0.00014862955637185647	SACS,SPAST,SETX
527	Ataxic	C0234366	3	35	8.95097052579e-05	0.0001489121220683809	TTR,ATM,SETX
528	Multiple Sclerosis	C0026769	19	1140	9.33802403247e-05	0.00014919468776490537	GFAP,APOE,PRSS3,GJC2,GRAP2,CFH,ALB,APOC1,APOC2,APOA1,CST3,CFB,SPAST,PDE4B,FN1,RANBP2,GABBR1,RYR2,PDZRN4
529	Microalbuminuria	C0730345	4	68	9.82216352328e-05	0.0001494772534614298	ALB,CST3,TTR,ATM
530	Chorea, childhood-onset, with psychomotor retardation	C0008489	5	109	9.94099320476e-05	0.00014975981915795424	GJC2,ATM,KCNMA1,TRAPPC11,SETX
531	Complete trisomy 18 syndrome	C0152096	3	36	0.000100169693823	0.00015004238485447866	APOA1,TTR,KCNMA1
532	Ataxia-telangiectasia syndrome	C0004135	7	212	0.000101710390239	0.0001503249505510031	APOC3,CFH,CFB,ATM,FN1,SETX,SLC1A5
535	Shock, Septic	C0036974	4	69	0.000105320764205	0.00015117264764057646	APOE,CFH,SCN5A,HP
536	Sleep apnea	C0037315	4	69	0.000105320764205	0.00015145521333710088	APOE,GSN,GABBR1,HP
537	Inclusion Body Myositis (disorder)	C0238190	4	69	0.000105320764205	0.00015173777903362533	APOE,CST3,TTR,GSN
538	Peripheral axonal neuropathy	C1263857	4	69	0.000105320764205	0.00015202034473014975	SERPING1,GJC2,TTR,SETX
539	Abnormality of cellular immune system	C4023612	10	406	0.000105744973285	0.0001523029104266742	PALB2,APOE,LDB3,TTN,KRT9,KRT1,ATM,SCN5A,DMD,SETX
540	Abnormal leukocyte count	C0152009	10	406	0.000105744973285	0.00015258547612319865	PALB2,APOE,LDB3,TTN,KRT9,KRT1,ATM,SCN5A,DMD,SETX
541	Ischemic Cerebrovascular Accident	C3272363	9	338	0.000107045760965	0.00015286804181972307	APOE,F7,CFH,ITGA2,AHSG,FABP4,ATM,PTGS1,CYP2C9
542	Steinert myotonic dystrophy syndrome	C0027126	6	160	0.00011155735196	0.00015315060751624755	APOE,LDB3,APOC1,APOC2,SCN5A,DMD
543	Corneal Diseases	C0010034	3	37	0.000111721997972	0.00015343317321277197	GFAP,APOE,GSN
544	Sudden death	C0011071	3	37	0.000111721997972	0.00015371573890929642	TTN,SCN5A,RYR2
545	Spastic	C0443306	3	37	0.000111721997972	0.00015399830460582084	APOE,GJC2,SPAST
546	Arrhythmogenic right ventricular cardiomyopathy, type 11	C0349788	4	70	0.000112807220368	0.0001542808703023453	GFAP,TTN,SCN5A,RYR2
547	Hypothyroidism	C0020676	9	341	0.00011506746995	0.00015456343599886974	KRT6A,APOE,APOC3,F7,SACS,TTR,GSN,NPHS1,NCOA3
548	Overweight	C0497406	7	217	0.000119494476613	0.00015484600169539417	FABP2,APOE,APOC3,GRAP2,APOA1,AHSG,LIPE
549	Hepatitis C	C0019196	14	721	0.000120139934171	0.00015512856739191864	APOE,APOC3,GRAP2,ALB,APOC1,APOC2,SCAF1,APOA1,ATM,APOA2,FN1,KRT14,TOMM40,HP
550	Ventricular Dysfunction, Right	C0242973	4	71	0.000120695102467	0.00015541113308844306	APOE,CST3,ATM,DMD
551	Inflammatory abnormality of the skin	C3875321	8	278	0.000121135959422	0.00015569369878496751	GJC2,KRT9,KRT1,APOA1,KRT16,KRT14,KRT10,KRT5
552	Pregnancy associated hypertension	C0852036	3	38	0.000124210467384	0.00015597626448149194	APOC3,LIPE,HP
553	Albuminuria	C0001925	6	163	0.000125230111093	0.00015625883017801639	APOE,CTSL,ALB,CST3,NPHS1,HP
554	Abnormality of fluid regulation	C2364164	9	346	0.000129567085062	0.00015654139587454083	CAMTA1,SERPING1,APOE,SLC25A13,GJC2,APOA1,NLRC4,FN1,NPHS1
653	Cerebroretinal microangiopathy with calcifications and cysts 1	C0155765	3	39	0.000137679765851	0.0001845153998304606	APOE,CFH,TTR
654	Abnormal albumin level	C4023036	3	39	0.000137679765851	0.00018479796552698502	ALB,FN1,NPHS1
655	Laryngomalacia	C0264303	3	39	0.000137679765851	0.00018508053122350945	KRT6A,KRT6B,KRT16
656	Adenocarcinoma of lung	C0152013	15	815	0.000138454573045	0.00018536309692003392	APOE,GRAP2,CFH,KLK3,ALB,APOC2,APOA1,GSN,ATM,KCNMA1,FN1,CLCA2,NCOA3,LAT,DICER1
657	Steatohepatitis	C2711227	7	222	0.00013977427029	0.00018564566261655834	APOE,SLC25A13,APOC3,APOC1,APOA1,AHSG,NCOA3
658	Abnormality of the musculature	C4021745	25	1765	0.000142913446953	0.0001859282283130828	GFAP,CAMTA1,LDB3,TTN,CRB1,F7,GJC2,KRT1,SACS,APOA1,TTR,GSN,ATM,SCN5A,DMD,TRAPPC11,AP4E1,SPAST,CHKB,KRT14,LIPE,OBSL1,SETX,DICER1,KRT5
659	Abnormality of the myocardium	C4025758	9	351	0.000145581998433	0.00018621079400960724	PALB2,LDB3,TTN,TTR,GSN,SCN5A,DMD,CHKB,RYR2
660	Neurotoxicity Syndromes	C0235032	3	40	0.00015217501421	0.0001864933597061317	ADRA1B,CYP2C9,LAT
661	Alcoholic Steatohepatitis	C2718067	3	40	0.00015217501421	0.00018677592540265612	APOE,BBC3,NLRC4
662	Abnormality of nervous system morphology	C4022810	26	1875	0.000152342007643	0.00018705849109918054	GFAP,CAMTA1,SERPING1,PALB2,APOE,LDB3,TTN,CRB1,SLC25A13,F7,GJC2,SACS,NLRC4,CST3,TTR,GSN,ATM,SCN5A,TRAPPC11,AP4E1,SPAST,FN1,CHKB,OBSL1,SETX,DICER1
663	Cerebellar ataxia, areflexia, pes cavus, optic atrophy and sensorinural hearing loss	C0007758	5	118	0.000153875201698	0.00018734105679570501	SACS,ATM,SPAST,FN1,SETX
664	Complications of Diabetes Mellitus	C0342257	4	75	0.000156554046638	0.00018762362249222944	APOE,F7,ALB,HP
665	Neoplasm by anatomical site	C4023185	12	576	0.000156738285694	0.0001879061881887539	PALB2,KRT6B,PLAG1,SLC25A13,KRT9,KRT1,ATM,FN1,KRT16,KRT14,DICER1,KRT5
673	CADASIL	C0751587	3	41	0.000167742024581	0.00019016671376094943	GFAP,APOE,FN1
674	Confusion	C0009676	3	41	0.000167742024581	0.00019044927945747388	APOE,SLC25A13,CFH
675	Abnormal QRS complex	C0205161	18	1098	0.000168246531584	0.0001907318451539983	SERPING1,KRT6A,APOE,KRT6B,LDB3,TTN,APOC2,APOA1,NLRC4,ATM,SCN5A,DMD,TRAPPC11,SPAST,KRT16,CHKB,LIPE,SETX
676	Abnormality of limbs	C0239337	20	1290	0.000174879075117	0.00019101441085052275	KRT6A,PALB2,LDB3,TTN,GJC2,KRT9,KRT1,SACS,DMD,TRAPPC11,AP4E1,SPAST,FN1,KRT16,KRT14,LIPE,OBSL1,SETX,KRT10,KRT5
677	Diabetes mellitus type 1	C0011854	18	1104	0.000180331502341	0.0001912969765470472	FABP2,GFAP,APOA4,APOE,APOC3,CTSL,CFH,ALB,APOC1,ITGA2,CFB,TTR,GSN,ATM,SCN5A,FN1,NPHS1,HP
678	Acute anterior uveitis	C0701807	3	42	0.000184426906506	0.00019157954224357162	SERPING1,CFH,CFB
679	Erythroblastosis	C0272138	3	42	0.000184426906506	0.00019186210794009607	PLAG1,KLK3,GSN
680	Malnutrition	C0162429	5	122	0.000184612953342	0.00019214467363662052	APOE,ALB,TTR,AHSG,CYP2C9
681	Liver Diseases	C0023895	12	586	0.000185399442115	0.00019242723933314497	APOE,SLC25A13,APOC3,F7,CFH,ALB,APOA1,CST3,ATM,FN1,CYP2C9,LAT
682	Dysmetria	C0234162	4	78	0.000188395592284	0.0001927098050296694	CAMTA1,GJC2,SACS,SETX
683	Abnormal peripheral nervous system morphology	C4025831	12	587	0.000188498845929	0.00019299237072619387	SERPING1,PALB2,LDB3,TTN,GJC2,SACS,NLRC4,TTR,GSN,SPAST,CHKB,SETX
